α-Glucosidase and α-amylase are enzymes which are associated with diabetic II. These enzymes break macromolecules of sugar into monosugar molecules which is soluble in body, hence increase the sugar level in blood. There is need to develop economical and save inhibitors to prevent them from breaking sugar macromolecules to soluble molecules which will control the level of sugar in blood. Therefore, we synthesized indole-based derivatives (1-18) and evaluated as dual inhibitor for α-glucosidase and α-amylase. These chemical scaffolds were built with variation in aryl ring which were found active with good to moderate activity for α-glucosidase having IC50 value ranging from 13.99 ± 0.10 to 59.09 ± 0.30 μM when compared with standard acarbose with IC50 of 11.29 ± 0.10 μM; for α-amylase IC50 value ranging from 13.14 ± 0.10 to 58.99 ± 0.30 μM when compared with the standard acarbose with IC50 of 11.12 ± 0.10 μM. Structure activity relationship (SAR) has been established for all compounds. Enzymatic kinetic study and molecular docking study have been carried out to investigate the binding interactions α-glucosidase and α-amylase enzyme.
Keywords: Enzymatic kinetic study; Indole; Molecular docking; α-Amylase; α-Glucosidase.
Copyright © 2020 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare no competing financial interests.
Synthesis of benzotriazoles derivatives and their dual potential as α-amylase and α-glucosidase inhibitors in vitro: Structure-activity relationship, molecular docking, and kinetic studies.Eur J Med Chem. 2019 Dec 1;183:111677. doi: 10.1016/j.ejmech.2019.111677. Epub 2019 Sep 5. Eur J Med Chem. 2019. PMID: 31514061
Syntheses, in vitro α-amylase and α-glucosidase dual inhibitory activities of 4-amino-1,2,4-triazole derivatives their molecular docking and kinetic studies.Bioorg Med Chem. 2020 Jun 1;28(11):115467. doi: 10.1016/j.bmc.2020.115467. Epub 2020 Apr 4. Bioorg Med Chem. 2020. PMID: 32327353
Novel C-2 Symmetric Molecules as α-Glucosidase and α-Amylase Inhibitors: Design, Synthesis, Kinetic Evaluation, Molecular Docking and Pharmacokinetics.Molecules. 2019 Apr 17;24(8):1511. doi: 10.3390/molecules24081511. Molecules. 2019. PMID: 30999646 Free PMC article.
Synthesis of new indazole based dual inhibitors of α-glucosidase and α-amylase enzymes, their in vitro, in silico and kinetics studies.Bioorg Chem. 2020 Jan;94:103195. doi: 10.1016/j.bioorg.2019.103195. Epub 2019 Aug 23. Bioorg Chem. 2020. PMID: 31451297
Pyrano[3,2-c]quinoline Derivatives as New Class of α-glucosidase Inhibitors to Treat Type 2 Diabetes: Synthesis, in vitro Biological Evaluation and Kinetic Study.Med Chem. 2019;15(1):8-16. doi: 10.2174/1573406414666180528110104. Med Chem. 2019. PMID: 29807519 Review.